A share price of Sensus Healthcare Inc [SRTS] is currently trading at $3.48, up 12.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SRTS shares have gain 6.42% over the last week, with a monthly amount glided 2.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sensus Healthcare Inc [NASDAQ: SRTS] stock has seen the most recent analyst activity on January 31, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $18. Previously, Maxim Group reaffirmed its Buy rating on November 15, 2024, and elevated its price target to $14. On February 26, 2021, upgrade upgraded it’s rating to Outperform. Northland Capital downgraded its rating to a Market Perform. Alliance Global Partners upgraded its rating to a Buy and raised its price target to $4.25 on August 10, 2020. Alliance Global Partners upgraded its rating to Buy for this stock on February 14, 2020, but kept the price target unchanged to $6. In a note dated November 07, 2019, B. Riley FBR downgraded a Neutral rating on this stock and revised its target price from $14 to $5.50.
Sensus Healthcare Inc experienced fluctuations in its stock price throughout the past year between $3.03 and $9.33. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Sensus Healthcare Inc [NASDAQ: SRTS] shares were valued at $3.48 at the most recent close of the market. An investor can expect a potential return of 187.36% based on the average SRTS price forecast.
Analyzing the SRTS fundamentals
Trailing Twelve Months sales for Sensus Healthcare Inc [NASDAQ:SRTS] were 37.56M which represents -20.82% decline. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.10 points at the first support level, and at 2.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.03, and for the 2nd resistance point, it is at 4.57.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Sensus Healthcare Inc [NASDAQ:SRTS] is 8.14. In addition, the Quick Ratio stands at 5.79 and the Cash Ratio stands at 3.46. Considering the valuation of this stock, the price to sales ratio is 1.52, the price to book ratio is 1.10.
Transactions by insiders
Recent insider trading involved Sardano Michael, PRESIDENT AND GENERAL COUNSEL, that happened on Aug 13 ’25 when 1000.0 shares were purchased. CHIEF FINANCIAL OFFICER, Rampolla Javier completed a deal on Feb 10 ’25 to buy 501.0 shares. Meanwhile, PRESIDENT AND GENERAL COUNSEL Sardano Michael bought 1000.0 shares on Feb 10 ’25.
